Hydroxychloroquine use and progression or prognosis of COVID-19: a systematic review and meta-analysis

Hydroxychloroquine (HCQ) has been implicated in antiviral activity in vitro against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, there is still controversy about whether HCQ should be used for coronavirus disease 2019 (COVID-19) patients due to the conflicting results in di...

Descripción completa

Detalles Bibliográficos
Autores principales: Zang, Yanxiang, Han, Xuejie, He, Meijiao, Shi, Jing, Li, Yue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7474863/
https://www.ncbi.nlm.nih.gov/pubmed/32892293
http://dx.doi.org/10.1007/s00210-020-01964-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7474863/
https://www.ncbi.nlm.nih.gov/pubmed/32892293
http://dx.doi.org/10.1007/s00210-020-01964-5

Ejemplares similares